0001375852-17-000004.txt : 20170711
0001375852-17-000004.hdr.sgml : 20170711
20170711201256
ACCESSION NUMBER: 0001375852-17-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170710
FILED AS OF DATE: 20170711
DATE AS OF CHANGE: 20170711
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Scott E
CENTRAL INDEX KEY: 0001375852
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 17960805
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-07-10
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001375852
Lamb Scott E
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
0
1
0
0
Chief Financial Officer,
Common Stock
2017-07-10
4
X
0
2998
46.53
A
9050
D
Common Stock
2017-07-10
4
S
0
2698
170.0355
D
6352
D
Common Stock
2017-07-10
4
S
0
300
171.0
D
6052
D
Common Stock
2017-07-11
4
X
0
20774
46.53
A
26826
D
Common Stock
2017-07-11
4
S
0
20774
170.0
D
6052
D
Non-Qualified Stock Option (right to buy)
46.53
2017-07-10
4
X
0
2998
46.53
D
2022-02-01
Common Stock
0
20774
D
Non-Qualified Stock Option (right to buy)
46.53
2017-07-11
4
X
0
20774
46.53
D
2022-02-01
Common Stock
0
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire, Attorney-in-fact For: Scott E. Lamb
2017-07-11